Literature DB >> 17418582

Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.

Kassoum Nacro1, Conxiang Charles Zha, Peter R Guzzo, R Jason Herr, Denise Peace, Thomas D Friedrich.   

Abstract

A series of A-ring and E-ring analogues of the natural product luotonin A, a known topoisomerase I poison, was evaluated for growth inhibition in human carcinoma and leukemia cell lines. Rational design of structures was based on analogues of the related alkaloid camptothecin, which has been demonstrated to exert cytotoxic effects by the same mechanism of action. When compared to luotonin A, several compounds exhibited an improved topoisomerase I-dependent growth inhibition of a human leukemia cell line.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418582     DOI: 10.1016/j.bmc.2007.03.067

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.

Authors:  Sivappa Rasapalli; Vamshikrishna Reddy Sammeta; Zachary F Murphy; James A Golen; Keli Agama; Yves Pommier; Sergey N Savinov
Journal:  Bioorg Med Chem Lett       Date:  2021-03-30       Impact factor: 2.940

Review 2.  Recent advances in the studies on luotonins.

Authors:  Jing Lu Liang; Hyo Chang Cha; Yurngdong Jahng
Journal:  Molecules       Date:  2011-06-14       Impact factor: 4.411

3.  Weinreb amidation as the cornerstone of an improved synthetic route to A-ring-modified derivatives of luotonin A.

Authors:  Norbert Haider; Simon Nuß
Journal:  Molecules       Date:  2012-09-25       Impact factor: 4.411

4.  A Facile Oxidative Opening of the C-Ring in Luotonin A and Derivatives.

Authors:  Amra Ibric; Kathrin Dutter; Brigitte Marian; Norbert Haider
Journal:  Molecules       Date:  2017-09-12       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.